
Keywords: MI; myocardial infarction; SSRI; selective serotonin reuptake inhibitor; LPS; lipopolysaccharide; IL; interleukin; MMP; matrix metalloproteinase; TIMP; tissue inhibitor of metalloproteinase; CIT; citalopram; LAD; left anterior descending coronary artery;